We use cookies to enhance the usability of our website. If you continue, we'll assume that you are happy to receive all cookies. More information. Don't show this again.
The Survival Scatter plot shows the clinical status (i.e. dead or alive) for all individuals in the patient cohort, based on the same data that underlies the corresponding Kaplan-Meier plots. Patients that are alive at last time for follow-up are shown in blue and patients who have died during the study are shown in red.
The x-axis shows the expression levels (FPKM) of the investigated gene in the tumor tissue at the time of diagnosis. The y-axis shows the follow-up time after diagnosis (years). Both axes are complimented with kernel density curves demonstrating the data density over the axes. The top density plot shows the expression levels (FPKM) distribution among dead (red) and alive patients (blue). The right density plot shows the data density of the survived years of dead patients with high and low expression levels respectively, stratified using the cutoff indicated by the vertical dashed line through the Survival Scatter plot. This cutoff is automatically defined based on the FPKM cutoff that minimizes the p-score. The cutoff can be changed by dragging the vertical line or by entering a cutoff value in the square labeled "Current cut-off".
Under the Survival Scatter plot the p-score landscape (black curve; left axis) is shown together with dead median separation (red curve; right axis). Dead median separation is the difference in median mRNA expression between patients who have died with high and low expression, respectively. It is calculated as follows: median FPKM expression of dead patients with high expression - median FPKM expression of dead patients with low expression. This is intended to aid the user in visually exploring custom cutoffs and the associated p-scores and dead median separation.
Individual patient data is displayed and can be filtered by clicking on one or more of the category buttons on the top of the page. Categories describing expression level and patient information include: high, low, alive, dead, female, male and tumor stages. The scale of the x-axis can be toggled between linear and log-scale by clicking on the "x log" button. Mouse-over function shows TCGA ID, patient information and mRNA expression (FPKM) for each patient.
& Survival analysisi
Kaplan-Meier plots summarize results from analysis of correlation between mRNA expression level and patient survival. Patients were divided based on level of expression into one of the two groups "low" (under cut off) or "high" (over cut off). X-axis shows time for survival (years) and y-axis shows the probability of survival, where 1.0 corresponds to 100 percent.
RPL15 is not prognostic in Ovary Serous Cystadenocarcinoma (TCGA)
Stage:
Survival analysis
Current cut offi
Current cut-off shows the cut-off (FPKM) currently selected. It may be changed manually. When the current cut-off is changed, the vertical dashed line indicating cut-off, the interactive survival scatter plot and the Kaplan-Meier curve will be automatically adjusted to show results accordingly.
:
Best expression cut offi
Based on the FPKM value of each gene, patients were classified into two groups and association between prognosis (survival) and gene expression (FPKM) was examined. The best expression cut-off refers the FPKM value that yields maximal difference with regard to survival between the two groups at the lowest log-rank P-value. Best expression cut-off was selected based on survival analysis .
When clicking on this number, the vertical dashed line indicating cut-off, the interactive survival plot, and the Kaplan-Meier curve will be adjusted to show results based on the best expression cut-off.
Median expression refers to the median FPKM value calculated based on the gene expression (FPKM) data from all patients in this dataset. When clicking on this number, the vertical dashed line indicating cut-off, the interactive survival plot, and the Kaplan-Meier curve will be adjusted to show results based on the median expression.
Median follow up time refers to the median time (years) after diagnosis with this type of cancer, based on clinical data from all patients in this dataset.
: N/A
P scorei
Log-rank P value for Kaplan-Meier plot showing results from analysis of correlation between mRNA expression level and patient survival.
N/A
5-year survival highi
5-year survival for patients with higher expression than the expression cutoff.
For melanoma and glioma, 3-year survival is shown.
N/A
5-year survival lowi
5-year survival for patients with lower expression than the expression cutoff.
For melanoma and glioma, 3-year survival is shown.
N/A
TCGA RNA samplesi
RNA-seq data is reported as average FPKM (number Fragments Per Kilobase of exon per Million reads), generated by the The Cancer Genome Atlas (TCGA) .
Normal distribution across the dataset is visualized with box plots, shown as median and 25th and 75th percentiles. Points are displayed as outliers if they are above or below 1.5 times the interquartile range. FPKM values of the individual samples are presented next to the box plot.
Average pTPM
4409.7
Number of samples
349
Samples
Sample
Description
pTPM
TCGA-29-2425-01A
60 years, female, white, stage:Stage IIIC, alive, 1977 days
12125.5
TCGA-25-1316-01A
55 years, female, white, stage:Stage IIIC, dead, 1279 days
10055.7
TCGA-29-1703-01A
56 years, female, black or african american, stage:Stage IIIC, dead, 1815 days
9938.8
TCGA-04-1350-01A
46 years, female, white, stage:Stage IIIC, dead, 1946 days
9811.8
TCGA-30-1853-01A
58 years, female, white, stage:Stage IIIC, dead, 1103 days
9691.0
TCGA-24-2023-01A
54 years, female, white, stage:Stage IIIA, dead, 1364 days
9581.7
TCGA-25-1634-01A
75 years, female, white, stage:Stage IIIC, dead, 1091 days
9474.9
TCGA-30-1891-01A
61 years, female, white, stage:Stage IIIC, dead, 914 days
9340.0
TCGA-24-1842-01A
49 years, female, white, stage:Stage IIIC, alive, 253 days
9241.3
TCGA-30-1861-01A
74 years, female, white, stage:Stage IIIC, dead, 1058 days
9204.4
TCGA-09-1673-01A
50 years, female, white, stage:Stage IV, alive, 92 days
8996.2
TCGA-25-1877-01A
81 years, female, white, stage:Stage IIIC, dead, 730 days
8720.0
TCGA-29-1784-01A
55 years, female, white, stage:Stage IIIC, alive, 163 days
8638.8
TCGA-24-1431-01A
67 years, female, white, stage:Stage IIIC, dead, 583 days
8612.6
TCGA-61-1907-01A
63 years, female, white, stage:Stage IIIC, alive, 952 days
8552.9
TCGA-24-2038-01A
68 years, female, white, stage:Stage IIIA, dead, 1354 days
8520.3
TCGA-29-1776-01A
63 years, female, black or african american, stage:Stage IIIC, alive, 360 days
8506.1
TCGA-61-1914-01A
65 years, female, stage:Stage IIIC, alive, 1722 days
8502.3
TCGA-25-2393-01A
81 years, female, white, stage:Stage IIIC, dead, 1157 days
8343.2
TCGA-29-1770-01A
54 years, female, white, stage:Stage IIIC, alive, 741 days
8329.2
TCGA-30-1866-01A
61 years, female, white, stage:Stage IV, dead, 1114 days
8286.8
TCGA-29-1778-01A
77 years, female, white, stage:Stage IIIC, alive, 454 days
7899.1
TCGA-30-1714-01A
68 years, female, white, stage:Stage IV, dead, 1158 days
7844.0
TCGA-13-1407-01A
51 years, female, white, stage:Stage IIIC, alive, 2534 days
7802.4
TCGA-24-2024-01A
72 years, female, black or african american, stage:Stage IIIC, dead, 1769 days
7763.0
TCGA-04-1655-01A
49 years, female, white, stage:Stage IIIB, dead, 1380 days
7716.0
TCGA-10-0931-01A
44 years, female, white, stage:Stage IIIC, dead, 1000 days
7626.0
TCGA-61-2002-01A
46 years, female, white, stage:Stage IIIC, alive, 547 days
7542.2
TCGA-24-1474-01A
57 years, female, black or african american, stage:Stage IIIC, dead, 676 days
7441.8
TCGA-30-1892-01A
52 years, female, white, stage:Stage IIIC, dead, 1484 days
7428.9
TCGA-61-2110-01A
56 years, female, white, stage:Stage IIIC, dead, 1354 days
7306.4
TCGA-13-1507-01A
77 years, female, white, stage:Stage IIIC, dead, 1993 days
7299.1
TCGA-09-1666-01A
57 years, female, white, stage:Stage IIIC, alive, 1752 days
7249.5
TCGA-61-1900-01A
51 years, female, black or african american, stage:Stage IIIB, alive, 176 days
7216.7
TCGA-24-2033-01A
87 years, female, white, stage:Stage IIIC, dead, 562 days
7127.3
TCGA-10-0927-01A
65 years, female, stage:Stage IIIC, dead, 2490 days
6956.8
TCGA-29-1769-01A
40 years, female, white, stage:Stage IIIC, alive, 699 days
6940.6
TCGA-13-1404-01A
48 years, female, white, stage:Stage IIIC, alive, 2469 days
6913.3
TCGA-61-1721-01A
38 years, female, white, stage:Stage IV, alive, 338 days
6859.9
TCGA-OY-A56Q-01A
78 years, female, black or african american, stage:Stage IIA, alive, 576 days
6856.6
TCGA-29-1701-01A
56 years, female, white, stage:Stage IIIC, dead, 515 days
6788.2
TCGA-61-1725-01A
40 years, female, white, stage:Stage IIIC, alive, 956 days
6716.7
TCGA-04-1341-01A
85 years, female, white, stage:'--, alive, 33 days
6664.6
TCGA-13-0762-01A
65 years, female, white, stage:Stage IIIC, alive, 3400 days
6648.7
TCGA-25-2400-01A
76 years, female, white, stage:Stage IIIC, dead, 1278 days
6644.1
TCGA-61-2008-01A
40 years, female, asian, stage:Stage IIC, alive, 932 days
6526.1
TCGA-25-1315-01A
50 years, female, white, stage:Stage IIIC, dead, 1583 days
6482.5
TCGA-29-2414-01A
75 years, female, white, stage:Stage IIIC, dead, 2621 days
6451.5
TCGA-24-1413-01A
51 years, female, white, stage:Stage IIIC, alive, 192 days
6330.1
TCGA-13-1498-01A
73 years, female, white, stage:Stage IIIC, dead, 2012 days
6330.1
TCGA-13-1501-01A
50 years, female, white, stage:Stage IV, dead, 1314 days
6274.6
TCGA-13-1495-01A
60 years, female, white, stage:Stage IIIC, dead, 2749 days
6215.6
TCGA-09-0364-01A
80 years, female, white, stage:Stage IIC, dead, 887 days
6196.0
TCGA-09-2048-01A
63 years, female, white, stage:Stage IIIC, dead, 138 days
6150.4
TCGA-13-1505-01A
63 years, female, white, stage:Stage IIIC, alive, 1998 days
6137.4
TCGA-61-1728-01A
59 years, female, white, stage:Stage IV, alive, 848 days
6131.9
TCGA-23-1030-01A
64 years, female, white, stage:Stage IIIC, alive, 886 days
6102.0
TCGA-61-1738-01A
60 years, female, black or african american, stage:Stage IIIC, dead, 1089 days
6101.6
TCGA-25-1630-01A
73 years, female, white, stage:Stage IIIC, dead, 1162 days
6058.3
TCGA-24-0979-01A
53 years, female, white, stage:Stage IV, dead, 1264 days
6044.9
TCGA-25-1632-01A
68 years, female, white, stage:Stage IV, dead, 1799 days
6012.2
TCGA-09-1669-01A
54 years, female, white, stage:Stage IIIA, alive, 928 days
5948.3
TCGA-36-1577-01A
43 years, female, asian, stage:Stage IIC, alive, 783 days
5931.7
TCGA-61-2009-01A
65 years, female, white, stage:Stage IIIC, alive, 1212 days
5924.5
TCGA-24-1563-01A
66 years, female, black or african american, stage:Stage IIIC, dead, 1451 days
5892.0
TCGA-29-1774-01A
82 years, female, white, stage:Stage IIIC, alive, 527 days
5852.5
TCGA-29-1777-01A
47 years, female, white, stage:Stage IIIC, alive, 374 days
5850.9
TCGA-24-1562-01A
67 years, female, white, stage:Stage IIIC, dead, 1384 days
5812.3
TCGA-29-1768-01A
50 years, female, white, stage:Stage IV, dead, 952 days
5812.2
TCGA-59-2350-01A
44 years, female, stage:Stage IV, dead, 679 days
5786.6
TCGA-23-2077-01A
45 years, female, white, stage:Stage IIIC, alive, 3525 days
5779.6
TCGA-13-0920-01A
65 years, female, white, stage:Stage IIIC, dead, 1484 days
5737.0
TCGA-13-0804-01A
73 years, female, white, stage:Stage IIIC, dead, 1073 days
5733.2
TCGA-23-1028-01A
43 years, female, white, stage:Stage IIIC, alive, 1503 days
5704.7
TCGA-36-1574-01A
48 years, female, asian, stage:Stage IIIC, alive, 686 days
5703.3
TCGA-24-1560-01A
51 years, female, white, stage:Stage IIIC, dead, 1341 days
5697.8
TCGA-61-2101-01A
55 years, female, white, stage:Stage IIIC, dead, 1688 days
5691.2
TCGA-61-2092-01A
57 years, female, white, stage:Stage IIIC, alive, 1573 days
5663.3
TCGA-61-1995-01A
43 years, female, white, stage:Stage IIIC, alive, 61 days
5653.1
TCGA-13-1510-01A
62 years, female, white, stage:Stage IIIC, dead, 1359 days
5635.5
TCGA-29-1761-01A
80 years, female, asian, stage:Stage IIIC, dead, 528 days
5599.1
TCGA-59-2355-01A
58 years, female, white, stage:Stage IV, dead, 65 days
5577.9
TCGA-61-1918-01A
45 years, female, white, stage:Stage IV, dead, 479 days
5555.2
TCGA-13-0765-01A
50 years, female, white, stage:Stage IIIC, dead, 1389 days
5528.9
TCGA-04-1519-01A
48 years, female, stage:Stage IIIC, alive, 24 days
5519.9
TCGA-24-1923-01A
51 years, female, white, stage:Stage IIIC, dead, 690 days
5452.9
TCGA-24-1419-01A
62 years, female, white, stage:Stage IIIC, alive, 239 days
5445.9
TCGA-61-2000-01A
67 years, female, white, stage:Stage IIIC, alive, 441 days
5428.0
TCGA-13-1483-01A
61 years, female, white, stage:Stage IIIC, dead, 895 days
5346.3
TCGA-23-1022-01A
67 years, female, white, stage:Stage IIIC, dead, 1511 days
5340.2
TCGA-09-0367-01A
67 years, female, native hawaiian or other pacific islander, stage:Stage IIIC, dead, 547 days
5324.3
TCGA-23-1110-01A
42 years, female, white, stage:Stage IIIC, alive, 1658 days
5318.1
TCGA-24-1924-01A
65 years, female, white, stage:Stage IIIC, dead, 919 days
5311.5
TCGA-20-1682-01A
56 years, female, white, stage:Stage IIIC, alive, 837 days
5309.0
TCGA-13-1410-01A
57 years, female, white, stage:Stage IV, alive, 2464 days
5304.0
TCGA-25-1631-01A
73 years, female, white, stage:Stage IIIC, dead, 9 days
5303.0
TCGA-30-1862-01A
65 years, female, white, stage:Stage IV, dead, 186 days
5289.4
TCGA-29-1766-01A
74 years, female, white, stage:Stage IIIC, dead, 1199 days
5232.8
TCGA-13-1506-01A
45 years, female, white, stage:Stage IIIC, dead, 1039 days
5208.5
TCGA-29-1694-01A
45 years, female, white, stage:Stage IIIC, dead, 1187 days
5208.2
TCGA-61-1998-01A
48 years, female, white, stage:Stage IIIC, alive, 168 days
5186.1
TCGA-24-0966-01A
78 years, female, black or african american, stage:Stage IIIC, alive, 232 days
5116.8
TCGA-23-1118-01A
45 years, female, white, stage:Stage IIIC, alive, 2616 days
5110.2
TCGA-24-1603-01A
53 years, female, white, stage:Stage IIIB, dead, 2742 days
5077.0
TCGA-24-1467-01A
51 years, female, white, stage:Stage IIIC, dead, 3224 days
5074.3
TCGA-29-1691-01A
51 years, female, white, stage:Stage IIIC, dead, 1470 days
5032.4
TCGA-23-1113-01A
48 years, female, white, stage:Stage IV, dead, 949 days
5028.2
TCGA-24-2020-01A
67 years, female, white, stage:Stage IIIC, dead, 4624 days
5010.5
TCGA-13-1487-01A
74 years, female, white, stage:Stage IV, dead, 681 days
4993.8
TCGA-13-1509-01A
64 years, female, white, stage:Stage IV, alive, 2438 days
4992.2
TCGA-24-1544-01A
71 years, female, black or african american, stage:Stage IIIC, dead, 820 days
4963.5
TCGA-61-1737-01A
42 years, female, white, stage:Stage IV, alive, 1364 days
4962.0
TCGA-23-1107-01A
59 years, female, white, stage:Stage IV, dead, 9 days
4902.9
TCGA-13-0766-01A
42 years, female, white, stage:Stage IIIC, dead, 1725 days
4899.4
TCGA-29-1783-01A
58 years, female, white, stage:Stage IIIC, alive, 220 days
4857.5
TCGA-24-0982-01A
77 years, female, white, stage:Stage IIIC, dead, 679 days
4839.6
TCGA-24-1471-01A
60 years, female, white, stage:Stage IIIC, alive, 36 days
4792.8
TCGA-24-1552-01A
77 years, female, white, stage:Stage IIIC, dead, 1259 days
4771.2
TCGA-25-2396-01A
71 years, female, white, stage:Stage IIIC, dead, 92 days
4760.6
TCGA-13-0887-01A
42 years, female, white, stage:Stage IIIC, dead, 2028 days
4738.9
TCGA-29-1696-01A
43 years, female, white, stage:Stage IIIC, dead, 1032 days
4734.0
TCGA-61-1919-01A
58 years, female, white, stage:Stage IIIC, dead, 1161 days
4727.3
TCGA-29-1711-01A
45 years, female, black or african american, stage:Stage IIIC, alive, 1053 days
4719.2
TCGA-61-1910-01A
56 years, female, white, stage:Stage IIC, alive, 1127 days
4697.9
TCGA-25-1328-01A
38 years, female, white, stage:Stage IIIC, dead, 2009 days
4691.9
TCGA-04-1362-01A
59 years, female, white, stage:Stage IIC, dead, 1348 days
4683.6
TCGA-29-1705-01A
47 years, female, white, stage:Stage IIIC, dead, 555 days
4679.1
TCGA-09-1662-01A
58 years, female, white, stage:Stage IV, dead, 2717 days
4674.1
TCGA-36-1580-01A
82 years, female, stage:Stage IIIC, dead, 737 days
4656.0
TCGA-24-1616-01A
56 years, female, white, stage:Stage IIIC, dead, 1163 days
4643.4
TCGA-61-2111-01A
61 years, female, white, stage:Stage IV, alive, 3825 days
4633.4
TCGA-25-2398-01A
71 years, female, white, stage:Stage IIIC, dead, 1369 days
4592.9
TCGA-57-1583-01A
57 years, female, black or african american, stage:Stage IIIC, dead, 346 days
4588.2
TCGA-31-1944-01A
47 years, female, white, stage:Stage IIIC, alive, 1386 days
4568.3
TCGA-24-1844-01A
64 years, female, white, stage:Stage IIIC, alive, 113 days
4554.6
TCGA-29-1690-01A
66 years, female, white, stage:Stage IIIC, dead, 1448 days
4522.9
TCGA-31-1956-01A
60 years, female, white, stage:Stage IIIB, alive, 1342 days
4522.5
TCGA-13-0795-01A
66 years, female, white, stage:Stage IIIC, dead, 619 days
4506.7
TCGA-23-1109-01A
62 years, female, white, stage:Stage IIIC, dead, 1562 days
4497.0
TCGA-04-1364-01A
61 years, female, white, stage:Stage IIIC, dead, 1024 days
4479.6
TCGA-24-1546-01A
46 years, female, white, stage:Stage IIIC, dead, 1955 days
4460.6
TCGA-24-1428-01A
50 years, female, white, stage:Stage IIIC, alive, 529 days
4440.1
TCGA-36-1570-01A
49 years, female, white, stage:Stage IIIC, alive, 655 days
4423.6
TCGA-24-1424-01A
67 years, female, white, stage:Stage IIIC, alive, 183 days
4416.9
TCGA-09-1670-01A
57 years, female, white, stage:Stage IIIA, alive, 547 days
4401.1
TCGA-30-1718-01A
44 years, female, white, stage:Stage IIIC, dead, 1579 days
4386.7
TCGA-23-2078-01A
66 years, female, white, stage:Stage IIIC, alive, 2661 days
4373.7
TCGA-24-2035-01A
65 years, female, white, stage:Stage IIIC, dead, 857 days
4330.6
TCGA-61-1724-01A
47 years, female, white, stage:Stage IIIC, dead, 637 days
4325.9
TCGA-24-1558-01A
73 years, female, white, stage:Stage IIIC, dead, 594 days
4312.8
TCGA-25-1323-01A
72 years, female, white, stage:Stage IIIC, dead, 395 days
4305.2
TCGA-29-1785-01A
55 years, female, white, stage:Stage IIIC, dead, 1104 days
4286.9
TCGA-24-1434-01A
59 years, female, white, stage:Stage IIIC, dead, 568 days
4276.9
TCGA-25-1627-01A
73 years, female, white, stage:Stage IIIC, dead, 394 days
4276.9
TCGA-59-2352-01A
78 years, female, white, stage:Stage IIIC, dead, 286 days
4272.0
TCGA-24-2281-01A
68 years, female, white, stage:Stage IIA, alive, 1357 days
4264.6
TCGA-13-0727-01A
71 years, female, white, stage:Stage IIIC, dead, 462 days
4264.3
TCGA-13-1409-01A
73 years, female, white, stage:Stage IIIC, dead, 1742 days
4259.2
TCGA-25-2409-01A
71 years, female, white, stage:Stage IV, dead, 821 days
4254.9
TCGA-24-1847-01A
45 years, female, white, stage:Stage IV, alive, 343 days
4251.1
TCGA-29-2427-01A
60 years, female, white, stage:Stage IIIC, alive, 1900 days
4246.1
TCGA-24-1604-01A
66 years, female, white, stage:Stage IIIC, dead, 2688 days
4238.3
TCGA-13-1403-01A
48 years, female, white, stage:Stage IIIC, dead, 2345 days
4221.2
TCGA-24-1418-01A
68 years, female, white, stage:Stage IIIC, alive, 243 days
4204.3
TCGA-13-0911-01A
55 years, female, white, stage:Stage IV, dead, 1355 days
4185.1
TCGA-24-2026-01A
79 years, female, white, stage:Stage IIIC, dead, 1059 days
4179.6
TCGA-59-2351-01A
51 years, female, white, stage:Stage IIIC, alive, 3532 days
4179.3
TCGA-23-1123-01A
59 years, female, white, stage:Stage IIIC, dead, 1018 days
4173.3
TCGA-25-1329-01A
76 years, female, white, stage:Stage IIIC, dead, 457 days
4158.4
TCGA-13-0883-01A
61 years, female, white, stage:Stage IIIC, dead, 2097 days
4151.8
TCGA-04-1514-01A
45 years, female, white, stage:Stage IIIA, dead, 1720 days
4144.4
TCGA-24-2254-01A
66 years, female, white, stage:Stage IIIC, dead, 1736 days
4115.4
TCGA-09-0366-01A
55 years, female, white, stage:Stage IIIC, dead, 1757 days
4095.2
TCGA-10-0938-01A
80 years, female, white, stage:Stage IIIC, dead, 636 days
4032.9
TCGA-25-1633-01A
64 years, female, white, stage:Stage IIIC, dead, 1891 days
4014.7
TCGA-23-1119-01A
64 years, female, white, stage:Stage IIIC, alive, 3953 days
4007.0
TCGA-24-1551-01A
53 years, female, white, stage:Stage IIIC, dead, 1579 days
4004.2
TCGA-WR-A838-01A
72 years, female, black or african american, stage:Stage IIIC, dead, 304 days
3979.5
TCGA-13-0886-01A
67 years, female, white, stage:Stage IIIC, alive, 4665 days
3972.9
TCGA-13-1488-01A
59 years, female, white, stage:Stage IV, dead, 2154 days
3969.3
TCGA-29-1697-01A
62 years, female, white, stage:Stage IIIC, dead, 949 days
3968.9
TCGA-24-2290-01A
56 years, female, white, stage:Stage IIIC, dead, 1102 days
3939.7
TCGA-13-0797-01A
49 years, female, white, stage:Stage IIIC, alive, 2121 days
3928.7
TCGA-25-1313-01A
62 years, female, white, stage:Stage IV, dead, 820 days
3914.8
TCGA-13-0885-01A
70 years, female, white, stage:Stage IIIC, alive, 3388 days
3913.6
TCGA-36-1568-01A
52 years, female, stage:Stage IIIC, alive, 875 days
3900.1
TCGA-36-1569-01A
52 years, female, white, stage:Stage IIIC, alive, 885 days
3893.4
TCGA-23-1122-01A
53 years, female, white, stage:Stage IIIC, dead, 1189 days
3890.4
TCGA-23-1027-01A
48 years, female, white, stage:Stage IIIC, dead, 976 days
3865.6
TCGA-24-1416-01A
34 years, female, white, stage:Stage IV, alive, 194 days
3863.8
TCGA-25-1317-01A
66 years, female, white, stage:Stage IIIC, dead, 61 days
3849.5
TCGA-13-1489-01A
70 years, female, white, stage:Stage IIIC, dead, 2553 days
3807.4
TCGA-61-1733-01A
71 years, female, white, stage:Stage IIIC, alive, 967 days
3804.0
TCGA-25-1321-01A
65 years, female, white, stage:Stage IIIC, dead, 1033 days
3763.6
TCGA-36-1571-01A
53 years, female, white, stage:Stage IIIB, dead, 695 days
3754.0
TCGA-57-1585-01A
57 years, female, white, stage:Stage IIIC, dead, 53 days
3736.7
TCGA-20-1686-01A
75 years, female, white, stage:Stage IIIC, alive, 89 days
3726.8
TCGA-04-1332-01A
70 years, female, white, stage:Stage IIIC, dead, 1247 days
3726.8
TCGA-57-1584-01A
47 years, female, white, stage:Stage IIIC, alive, 643 days
3719.1
TCGA-25-2401-01A
64 years, female, white, stage:Stage IIIC, dead, 90 days
3718.8
TCGA-13-0725-01A
44 years, female, white, stage:Stage IIIC, dead, 377 days
3717.9
TCGA-24-1549-01A
58 years, female, white, stage:Stage IIIB, dead, 1721 days
3701.6
TCGA-04-1542-01A
52 years, female, white, stage:Stage IIIB, dead, 2561 days
3698.7
TCGA-25-1870-01A
59 years, female, white, stage:Stage IIIC, dead, 455 days
3695.3
TCGA-13-0726-01A
55 years, female, white, stage:Stage IIIC, dead, 949 days
3691.8
TCGA-13-0916-01A
49 years, female, white, stage:Stage IIIC, alive, 1785 days
3666.4
TCGA-04-1343-01A
72 years, female, white, stage:Stage IV, dead, 361 days
3656.5
TCGA-5X-AA5U-01A
61 years, female, black or african american, stage:Stage IIC, alive, 361 days
3652.8
TCGA-09-2054-01A
58 years, female, black or african american, stage:Stage IIIC, dead, 637 days
3652.4
TCGA-25-1319-01A
73 years, female, white, stage:Stage IIIC, dead, 1977 days
3642.7
TCGA-25-1312-01A
69 years, female, white, stage:Stage IV, dead, 31 days
3618.2
TCGA-24-1427-01A
58 years, female, stage:Stage IIIC, alive, 147 days
3607.9
TCGA-24-1435-01A
57 years, female, white, stage:Stage IIIC, dead, 1324 days
3587.2
TCGA-31-1946-01A
30 years, female, stage:Stage IIIC, alive, 918 days
3550.7
TCGA-13-0724-01A
72 years, female, white, stage:Stage IV, dead, 83 days
3549.3
TCGA-13-0800-01A
52 years, female, white, stage:Stage IIIC, alive, 2661 days
3531.5
TCGA-29-1781-01A
69 years, female, white, stage:Stage IIIC, alive, 255 days
3522.4
TCGA-25-2399-01A
80 years, female, white, stage:Stage IIIC, dead, 608 days
3511.0
TCGA-61-2098-01A
62 years, female, white, stage:Stage IIIC, alive, 1993 days
3510.4
TCGA-13-A5FT-01A
67 years, female, black or african american, stage:Stage IIIC, alive, 2143 days
3483.8
TCGA-24-1464-01A
70 years, female, white, stage:Stage IIIC, dead, 379 days
3465.0
TCGA-23-1111-01A
63 years, female, white, stage:Stage IIIC, alive, 98 days
3456.2
TCGA-VG-A8LO-01A
55 years, female, black or african american, stage:Stage IV, dead, 24 days
3445.0
TCGA-13-0923-01A
74 years, female, white, stage:Stage IIIC, alive, 2547 days
3435.1
TCGA-10-0937-01A
44 years, female, white, stage:Stage IIIC, dead, 608 days
3427.6
TCGA-23-2084-01A
45 years, female, white, stage:Stage IV, dead, 1516 days
3400.8
TCGA-29-1688-01A
39 years, female, white, stage:Stage IIIC, dead, 2400 days
3397.8
TCGA-04-1361-01A
57 years, female, white, stage:Stage IIIB, alive, 989 days
3340.1
TCGA-29-2428-01A
58 years, female, white, stage:Stage IIIC, alive, 1372 days
3338.5
TCGA-25-1326-01A
61 years, female, white, stage:Stage IIIC, dead, 1249 days
3310.0
TCGA-25-1635-01A
71 years, female, white, stage:Stage IIIC, dead, 1583 days
3308.3
TCGA-61-2097-01A
71 years, female, white, stage:Stage IIC, alive, 1844 days
3289.9
TCGA-13-0891-01A
73 years, female, white, stage:Stage IV, dead, 3128 days
3285.6
TCGA-24-1104-01A
56 years, female, white, stage:Stage IV, dead, 1933 days
3279.5
TCGA-24-2261-01A
76 years, female, white, stage:Stage IIIC, dead, 24 days
3272.9
TCGA-23-1024-01A
52 years, female, white, stage:Stage IV, alive, 468 days
3256.2
TCGA-13-0897-01A
54 years, female, white, stage:Stage IIIC, dead, 2182 days
3255.3
TCGA-57-1586-01A
66 years, female, white, stage:Stage IIIC, alive, 679 days
3249.4
TCGA-59-2363-01A
40 years, female, asian, stage:Stage IIIA, alive, 165 days
3241.9
TCGA-13-1411-01A
81 years, female, white, stage:Stage IIIC, dead, 531 days
3236.2
TCGA-13-1477-01A
49 years, female, white, stage:Stage IV, dead, 1662 days
3229.6
TCGA-24-1565-01A
74 years, female, white, stage:Stage IIIC, dead, 312 days
3226.0
TCGA-23-1116-01A
83 years, female, white, stage:Stage IIIC, dead, 592 days
3222.0
TCGA-23-1023-01A
65 years, female, white, stage:Stage IIIC, alive, 1233 days
3218.4
TCGA-25-2392-01A
75 years, female, white, stage:Stage IV, dead, 31 days
3188.9
TCGA-24-1105-01A
36 years, female, white, stage:Stage IIIC, dead, 1442 days
3181.8
TCGA-13-1496-01A
65 years, female, white, stage:Stage IIIC, dead, 129 days
3178.4
TCGA-57-1994-01A
63 years, female, white, stage:'--, alive, 761 days
3177.4
TCGA-25-2404-01A
38 years, female, american indian or alaska native, stage:Stage IIIC, dead, 883 days
3171.9
TCGA-24-1567-01A
54 years, female, white, stage:Stage IIIB, dead, 524 days
3157.7
TCGA-24-2289-01A
68 years, female, white, stage:Stage IV, dead, 2049 days
3157.7
TCGA-13-1405-01A
49 years, female, white, stage:Stage IV, dead, 868 days
3156.5
TCGA-24-1553-01A
53 years, female, white, stage:Stage IIIB, dead, 1767 days
3156.0
TCGA-61-1741-01A
76 years, female, white, stage:Stage IIIB, dead, 1024 days
3155.5
TCGA-57-1582-01A
50 years, female, white, stage:Stage IIIC, dead, 731 days
3139.8
TCGA-13-1492-01A
66 years, female, white, stage:Stage IIIC, dead, 3819 days
3120.5
TCGA-13-0714-01A
55 years, female, white, stage:Stage IV, dead, 189 days
3116.2
TCGA-20-1687-01A
46 years, female, white, stage:Stage IV, alive, 81 days
3112.4
TCGA-09-2045-01A
50 years, female, asian, stage:Stage IV, dead, 1069 days
3093.6
TCGA-30-1860-01A
58 years, female, white, stage:Stage IIIC, dead, 1366 days
3089.5
TCGA-24-1469-01A
71 years, female, white, stage:Stage IIIC, alive, 277 days
3077.6
TCGA-13-0720-01A
48 years, female, white, stage:Stage IIIC, dead, 1355 days
3075.5
TCGA-24-1846-01A
45 years, female, stage:Stage IIIC, alive, 133 days
3070.2
TCGA-29-A5NZ-01A
66 years, female, black or african american, stage:Stage IIIC, dead, 1088 days
3063.0
TCGA-24-1417-01A
54 years, female, white, stage:Stage IV, alive, 238 days
3041.4
TCGA-24-1850-01A
72 years, female, white, stage:Stage IIIC, alive, 168 days
3017.1
TCGA-20-1683-01A
65 years, female, white, stage:Stage IIIC, alive, 772 days
3013.2
TCGA-24-1423-01A
61 years, female, white, stage:Stage IIIC, alive, 190 days
3008.2
TCGA-61-2109-01A
40 years, female, white, stage:Stage IIIC, dead, 629 days
2994.3
TCGA-59-2354-01A
63 years, female, white, stage:Stage IIIC, dead, 1046 days
2987.1
TCGA-24-1928-01A
77 years, female, white, stage:Stage IIIC, dead, 336 days
2982.7
TCGA-24-2280-01A
74 years, female, white, stage:Stage IIIC, alive, 2143 days
2978.2
TCGA-29-1695-01A
62 years, female, white, stage:Stage IIIC, dead, 1229 days
2970.9
TCGA-61-2003-01A
53 years, female, white, stage:Stage IIIC, alive, 122 days
2945.2
TCGA-23-1809-01A
63 years, female, white, stage:Stage IIC, alive, 16 days
2942.6
TCGA-29-1693-01A
72 years, female, white, stage:Stage IIIC, alive, 3096 days
2904.4
TCGA-29-1762-01A
59 years, female, white, stage:Stage IV, dead, 2634 days
2891.1
TCGA-24-2267-01A
58 years, female, white, stage:Stage IIB, dead, 1446 days
2878.3
TCGA-24-1426-01A
43 years, female, white, stage:Stage IIIC, alive, 163 days
2864.9
TCGA-25-1318-01A
54 years, female, white, stage:Stage IIIC, dead, 1064 days
2858.2
TCGA-13-2060-01A
51 years, female, white, stage:Stage IV, alive, 2369 days
2849.4
TCGA-23-1120-01A
60 years, female, white, stage:Stage IIIC, alive, 130 days
2806.9
TCGA-36-1576-01A
76 years, female, stage:Stage IIIC, alive, 915 days
2806.0
TCGA-31-1953-01A
52 years, female, asian, stage:Stage IIIC, alive, 204 days
2799.9
TCGA-24-1425-01A
45 years, female, white, stage:Stage IIIC, alive, 181 days
2791.5
TCGA-04-1651-01A
53 years, female, white, stage:Stage IIIC, dead, 1102 days
2781.8
TCGA-61-1911-01A
55 years, female, white, stage:Stage IIA, alive, 1293 days
2774.5
TCGA-57-1993-01A
56 years, female, white, stage:Stage IIIC, alive, 763 days
2766.8
TCGA-24-1843-01A
66 years, female, white, stage:Stage IIIC, alive, 106 days
2707.0
TCGA-25-1626-01A
65 years, female, white, stage:Stage IIIC, dead, 518 days
2703.1
TCGA-24-1422-01A
82 years, female, black or african american, stage:Stage IIIC, dead, 23 days
2699.1
TCGA-04-1530-01A
68 years, female, white, stage:Stage IIIC, dead, 3622 days
2685.8
TCGA-09-2051-01A
42 years, female, white, stage:Stage IIIC, alive, 1919 days
2684.6
TCGA-04-1648-01A
57 years, female, white, stage:Stage IIIC, dead, 871 days
2674.0
TCGA-10-0928-01A
71 years, female, white, stage:Stage IIIC, dead, 563 days
2636.0
TCGA-13-0730-01A
71 years, female, white, stage:Stage IIIC, dead, 542 days
2632.7
TCGA-24-1930-01A
53 years, female, white, stage:Stage IIIC, dead, 2467 days
2587.4
TCGA-04-1347-01A
81 years, female, white, stage:Stage IV, alive, 1919 days
2582.0
TCGA-25-1623-01A
71 years, female, white, stage:Stage IV, dead, 565 days
2572.2
TCGA-04-1356-01A
62 years, female, white, stage:Stage IIC, dead, 1499 days
2564.7
TCGA-31-1959-01A
49 years, female, white, stage:Stage IV, alive, 67 days
2521.8
TCGA-29-1710-01A
54 years, female, white, stage:Stage IIIC, dead, 951 days
2503.2
TCGA-24-1550-01A
49 years, female, white, stage:Stage IIIC, dead, 1249 days
2496.3
TCGA-59-A5PD-01A
55 years, female, black or african american, stage:Stage IC, dead, 624 days
2494.8
TCGA-13-1499-01A
56 years, female, white, stage:Stage IIIC, alive, 3500 days
2487.1
TCGA-31-1950-01A
76 years, female, white, stage:Stage IIIC, alive, 571 days
2481.6
TCGA-24-2036-01A
50 years, female, white, stage:Stage IIIA, dead, 1947 days
2481.0
TCGA-24-2298-01A
55 years, female, white, stage:Stage IIIC, dead, 1620 days
2480.6
TCGA-25-1628-01A
67 years, female, white, stage:Stage IIIC, dead, 627 days
2471.1
TCGA-25-1322-01A
62 years, female, white, stage:Stage IV, dead, 91 days
2451.0
TCGA-24-1430-01A
68 years, female, white, stage:Stage IIIC, dead, 863 days
2445.0
TCGA-13-0924-01A
45 years, female, white, stage:Stage IV, alive, 2614 days
2443.6
TCGA-24-0968-01A
59 years, female, white, stage:Stage IIIC, dead, 598 days
2442.2
TCGA-24-1845-01A
42 years, female, white, stage:Stage IIIC, alive, 116 days
2437.3
TCGA-31-1951-01A
58 years, female, white, stage:Stage IIIC, alive, 684 days
2399.3
TCGA-24-2288-01A
70 years, female, white, stage:Stage IIIC, dead, 25 days
2399.1
TCGA-20-0991-01A
78 years, female, white, stage:Stage IIB, alive, 797 days
2390.0
TCGA-04-1338-01A
78 years, female, white, stage:Stage IIIC, alive, 1418 days
2347.9
TCGA-24-2027-01A
51 years, female, white, stage:Stage IV, dead, 3337 days
2331.4
TCGA-13-1485-01A
48 years, female, white, stage:Stage IV, dead, 629 days
2280.7
TCGA-24-2293-01A
47 years, female, white, stage:'--, dead, 506 days
2280.7
TCGA-24-1103-01A
50 years, female, black or african american, stage:Stage IIIC, dead, 1646 days
2277.8
TCGA-29-1763-01A
43 years, female, black or african american, stage:Stage IIC, alive, 2032 days
2220.7
TCGA-61-2012-01A
81 years, female, white, stage:Stage IIC, alive, 932 days
2216.6
TCGA-25-1320-01A
65 years, female, white, stage:Stage IIIC, dead, 1155 days
2191.5
TCGA-61-2104-01A
53 years, female, white, stage:Stage IIC, alive, 2338 days
2177.5
TCGA-25-2042-01A
60 years, female, american indian or alaska native, stage:Stage IIIC, dead, 396 days
2161.5
TCGA-13-1408-01A
59 years, female, white, stage:Stage IIIC, dead, 1680 days
2152.8
TCGA-13-1497-01A
47 years, female, white, stage:Stage IIIC, alive, 3871 days
2140.3
TCGA-30-1857-01A
64 years, female, white, stage:Stage IV, dead, 8 days
2111.7
TCGA-09-0369-01A
56 years, female, white, stage:Stage IIIC, dead, 1082 days
2100.7
TCGA-04-1331-01A
78 years, female, white, stage:Stage IIIC, dead, 1336 days
2013.2
TCGA-13-1512-01A
49 years, female, white, stage:Stage IIIC, alive, 442 days
1996.3
TCGA-13-0888-01A
78 years, female, white, stage:Stage IIIC, dead, 2811 days
1958.4
TCGA-59-2348-01A
59 years, female, white, stage:Stage IIIC, alive, 5481 days
1930.1
TCGA-04-1365-01A
87 years, female, white, stage:Stage IIIB, alive, 947 days
1896.8
TCGA-13-0768-01A
73 years, female, white, stage:Stage IIIC, dead, 1784 days
1886.6
TCGA-36-1581-01A
63 years, female, white, stage:Stage IIC, alive, 751 days
1862.1
TCGA-24-2271-01A
55 years, female, asian, stage:Stage IIIC, dead, 962 days
1834.1
TCGA-61-2102-01A
74 years, female, white, stage:Stage IIIC, dead, 197 days
1768.4
TCGA-24-1557-01A
49 years, female, white, stage:Stage IIIC, dead, 1213 days
1738.3
TCGA-10-0933-01A
77 years, female, white, stage:Stage IIIC, dead, 446 days
1725.4
TCGA-13-0906-01A
50 years, female, white, stage:Stage IIIC, alive, 3619 days
1711.7
TCGA-04-1536-01A
60 years, female, black or african american, stage:Stage IV, dead, 885 days
1671.6
TCGA-20-0987-01A
61 years, female, white, stage:Stage IIIC, dead, 701 days
1648.5
TCGA-61-2088-01A
51 years, female, white, stage:Stage IIIC, alive, 145 days
1344.3
TCGA-24-2297-01A
56 years, female, white, stage:Stage IIIC, dead, 1699 days
1291.8
TCGA-13-1511-01A
52 years, female, asian, stage:Stage IV, dead, 1650 days
1258.8
TCGA-61-2113-01A
53 years, female, white, stage:Stage IIC, dead, 676 days
The Survival Scatter plot shows the clinical status (i.e. dead or alive) for all individuals in the patient cohort, based on the same data that underlies the corresponding Kaplan-Meier plots. Patients that are alive at last time for follow-up are shown in blue and patients who have died during the study are shown in red.
The x-axis shows the expression levels (FPKM) of the investigated gene in the tumor tissue at the time of diagnosis. The y-axis shows the follow-up time after diagnosis (years). Both axes are complimented with kernel density curves demonstrating the data density over the axes. The top density plot shows the expression levels (FPKM) distribution among dead (red) and alive patients (blue). The right density plot shows the data density of the survived years of dead patients with high and low expression levels respectively, stratified using the cutoff indicated by the vertical dashed line through the Survival Scatter plot. This cutoff is automatically defined based on the FPKM cutoff that minimizes the p-score. The cutoff can be changed by dragging the vertical line or by entering a cutoff value in the square labeled "Current cut-off".
Under the Survival Scatter plot the p-score landscape (black curve; left axis) is shown together with dead median separation (red curve; right axis). Dead median separation is the difference in median mRNA expression between patients who have died with high and low expression, respectively. It is calculated as follows: median FPKM expression of dead patients with high expression - median FPKM expression of dead patients with low expression. This is intended to aid the user in visually exploring custom cutoffs and the associated p-scores and dead median separation.
Individual patient data is displayed and can be filtered by clicking on one or more of the category buttons on the top of the page. Categories describing expression level and patient information include: high, low, alive, dead, female, male and tumor stages. The scale of the x-axis can be toggled between linear and log-scale by clicking on the "x log" button. Mouse-over function shows TCGA ID, patient information and mRNA expression (FPKM) for each patient.
& Survival analysisi
Kaplan-Meier plots summarize results from analysis of correlation between mRNA expression level and patient survival. Patients were divided based on level of expression into one of the two groups "low" (under cut off) or "high" (over cut off). X-axis shows time for survival (years) and y-axis shows the probability of survival, where 1.0 corresponds to 100 percent.
RPL15 is not prognostic in Ovary Serous Cystadenocarcinoma (validation)
Stage:
Survival analysis
Current cut offi
Current cut-off shows the cut-off (FPKM) currently selected. It may be changed manually. When the current cut-off is changed, the vertical dashed line indicating cut-off, the interactive survival scatter plot and the Kaplan-Meier curve will be automatically adjusted to show results accordingly.
:
Best expression cut offi
Based on the FPKM value of each gene, patients were classified into two groups and association between prognosis (survival) and gene expression (FPKM) was examined. The best expression cut-off refers the FPKM value that yields maximal difference with regard to survival between the two groups at the lowest log-rank P-value. Best expression cut-off was selected based on survival analysis .
When clicking on this number, the vertical dashed line indicating cut-off, the interactive survival plot, and the Kaplan-Meier curve will be adjusted to show results based on the best expression cut-off.
Median expression refers to the median FPKM value calculated based on the gene expression (FPKM) data from all patients in this dataset. When clicking on this number, the vertical dashed line indicating cut-off, the interactive survival plot, and the Kaplan-Meier curve will be adjusted to show results based on the median expression.
Median follow up time refers to the median time (years) after diagnosis with this type of cancer, based on clinical data from all patients in this dataset.
: N/A
P scorei
Log-rank P value for Kaplan-Meier plot showing results from analysis of correlation between mRNA expression level and patient survival.
N/A
5-year survival highi
5-year survival for patients with higher expression than the expression cutoff.
For melanoma and glioma, 3-year survival is shown.
N/A
5-year survival lowi
5-year survival for patients with lower expression than the expression cutoff.
For melanoma and glioma, 3-year survival is shown.
N/A
TCGA RNA samplesi
RNA-seq data is reported as average FPKM (number Fragments Per Kilobase of exon per Million reads), generated by the The Cancer Genome Atlas (TCGA) .
Normal distribution across the dataset is visualized with box plots, shown as median and 25th and 75th percentiles. Points are displayed as outliers if they are above or below 1.5 times the interquartile range. FPKM values of the individual samples are presented next to the box plot.
Average pTPM
1939.8
Number of samples
81
Samples
Sample
Description
pTPM
DO46518
62 years, female, NA, stage:III, alive, 2960 days
4745.5
DO46404
55 years, female, NA, stage:III, dead, 690 days
4241.9
DO46402
77 years, female, NA, stage:III, dead, 511 days
4133.8
DO46384
55 years, female, NA, stage:III, dead, 614 days
3976.1
DO46338
59 years, female, NA, stage:III, dead, 596 days
3849.9
DO46390
65 years, female, NA, stage:III, dead, 374 days
3259.7
DO46328
52 years, female, NA, stage:III, dead, 972 days
3246.2
DO46566
78 years, female, NA, stage:III, dead, 673 days
2876.7
DO46561
52 years, female, NA, stage:III, dead, 195 days
2790.5
DO46463
49 years, female, NA, stage:III, dead, 2451 days
2705.0
DO46326
51 years, female, NA, stage:III, dead, 701 days
2678.4
DO46438
55 years, female, NA, stage:IV, alive, 2227 days
2668.4
DO46392
48 years, female, NA, stage:III, dead, 628 days
2503.1
DO46356
68 years, female, NA, stage:III, dead, 911 days
2472.6
DO46443
59 years, female, NA, stage:III, dead, 2464 days
2432.0
DO46334
77 years, female, NA, stage:III, dead, 496 days
2429.0
DO46508
50 years, female, NA, stage:III, dead, 2101 days
2409.8
DO46400
70 years, female, NA, stage:III, dead, 719 days
2392.7
DO46560
45 years, female, NA, stage:IV, dead, 286 days
2378.3
DO46568
66 years, female, NA, stage:III, dead, 320 days
2377.1
DO46513
54 years, female, NA, stage:IV, dead, 1883 days
2343.1
DO46362
61 years, female, NA, stage:III, dead, 1639 days
2320.1
DO46370
54 years, female, NA, stage:III, dead, 1727 days
2311.6
DO46388
74 years, female, NA, stage:III, dead, 413 days
2267.0
DO46597
60 years, female, NA, stage:III, dead, 393 days
2265.0
DO46380
51 years, female, NA, stage:III, dead, 1423 days
2199.9
DO46576
75 years, female, NA, stage:III, alive, 133 days
2182.5
DO46533
46 years, female, NA, stage:III, alive, 3667 days
2155.2
DO46376
58 years, female, NA, stage:III, dead, 1430 days
2138.9
DO46344
46 years, female, NA, stage:III, dead, 642 days
2124.4
DO46360
58 years, female, NA, stage:IV, dead, 1759 days
2109.1
DO46581
66 years, female, NA, stage:III, dead, 408 days
2098.7
DO46523
52 years, female, NA, stage:IV, alive, 1873 days
2054.0
DO46330
60 years, female, NA, stage:III, dead, 684 days
1977.5
DO46394
61 years, female, NA, stage:IV, dead, 1039 days
1956.8
DO46331
72 years, female, NA, stage:III, dead, 612 days
1954.6
DO46602
74 years, female, NA, stage:III, dead, 205 days
1886.1
DO46342
67 years, female, NA, stage:III, dead, 1398 days
1853.7
DO46327
54 years, female, NA, stage:III, dead, 184 days
1845.6
DO46336
70 years, female, NA, stage:IV, dead, 664 days
1802.7
DO46378
59 years, female, NA, stage:III, alive, 843 days
1801.7
DO46606
73 years, female, NA, stage:III, alive, 804 days
1776.1
DO46588
74 years, female, NA, stage:III, dead, 438 days
1764.2
DO46538
57 years, female, NA, stage:III, dead, 1527 days
1749.4
DO46546
73 years, female, NA, stage:III, dead, 1889 days
1746.1
DO46333
58 years, female, NA, stage:III, dead, 359 days
1729.6
DO46325
54 years, female, NA, stage:III, dead, 477 days
1725.4
DO46386
49 years, female, NA, stage:III, dead, 1162 days
1715.5
DO46352
60 years, female, NA, stage:III, dead, 677 days
1682.6
DO46453
66 years, female, NA, stage:III, dead, 3294 days
1651.1
DO46398
66 years, female, NA, stage:III, alive, 437 days
1615.8
DO46408
56 years, female, NA, stage:III, dead, 489 days
1581.7
DO46396
64 years, female, NA, stage:III, dead, 583 days
1562.5
DO46493
62 years, female, NA, stage:IV, alive, 839 days
1544.1
DO46340
62 years, female, NA, stage:III, dead, 616 days
1542.0
DO46346
54 years, female, NA, stage:III, dead, 1187 days
1530.5
DO46358
60 years, female, NA, stage:III, dead, 423 days
1475.2
DO46432
56 years, female, NA, stage:III, alive, 2218 days
1464.9
DO46332
56 years, female, NA, stage:III, dead, 689 days
1461.6
DO46372
39 years, female, NA, stage:III, dead, 1326 days
1374.3
DO46591
58 years, female, NA, stage:III, dead, 195 days
1354.3
DO46374
69 years, female, NA, stage:III, dead, 1409 days
1288.4
DO46448
45 years, female, NA, stage:III, dead, 654 days
1271.1
DO46528
56 years, female, NA, stage:III, alive, 6139 days
1247.4
DO46458
67 years, female, NA, stage:IV, alive, 3787 days
1233.2
DO46348
58 years, female, NA, stage:IV, dead, 287 days
1205.3
DO46382
62 years, female, NA, stage:IV, dead, 311 days
1203.6
DO46364
45 years, female, NA, stage:III, dead, 806 days
1195.6
DO46412
64 years, female, NA, stage:III, dead, 597 days
1185.0
DO46354
73 years, female, NA, stage:III, dead, 843 days
1157.6
DO46586
55 years, female, NA, stage:III, dead, 1019 days
1074.4
DO46551
58 years, female, NA, stage:III, dead, 1055 days
1011.1
DO46571
61 years, female, NA, stage:III, dead, 243 days
1008.1
DO46350
66 years, female, NA, stage:III, dead, 886 days
1007.4
DO46611
52 years, female, NA, stage:III, dead, 734 days
957.2
DO46329
52 years, female, NA, stage:III, dead, 1699 days
945.7
DO46428
59 years, female, NA, stage:IV, alive, 2644 days
831.3
DO46436
58 years, female, NA, stage:III, alive, 3193 days
826.8
DO46368
57 years, female, NA, stage:III, dead, 2879 days
772.5
DO46366
65 years, female, NA, stage:III, dead, 2054 days
756.1
DO46468
67 years, female, NA, stage:III, alive, 2776 days
689.6
Show allShow less
OVARY SEROUS CYSTADENOCARCINOMA - Protein relative expression (CPTAC)
Number of samples
108
Samples
Sample ID
Sample type
nRPX
0cc794c3-5bf5-4621-b238-58a0f6_D2
Tumor
0.5
8d78194e-fbef-4819-a7b5-b73ae9_D2
Tumor
0.4
9e0d47e0-f633-468b-b82b-4d752d_D2
Tumor
0.4
eb3f3494-7057-4afe-b212-e6e9a3_D2
Tumor
0.4
74a45e5a-a35a-4c60-a4b4-f3f5ea_D2
Tumor
0.4
51c1c79e-5a8e-4b0a-bf92-1c0cab_D2
Tumor
0.3
fbb41c94-aabd-49cc-90b2-882c3e_D2
Tumor
0.3
10c2d629-0287-4511-ac25-f29031_D2
Tumor
0.3
2ed8beb2-bc63-4bad-b5fe-1916a0_D2
Tumor
0.2
927f0958-db5a-4bc5-92b7-2a3695_D2
Tumor
0.2
08296da7-70ea-44df-8646-09f2cc_D2
Tumor
0.1
0c87932d-b6fd-4eb5-b86a-a34d07_D2
Tumor
0.1
e3ebe010-cd31-4b5d-8fcb-b7103b_D2
Tumor
0.0
35a345a4-e954-4c81-ae3f-7797cd_D2
Tumor
0.0
5ea22f5e-307b-491d-801f-8b7fa6_D2
Tumor
0.0
8e17b45e-6a06-4e4e-913d-7b1edb_D2
Tumor
0.0
3946a96c-e0ae-442f-83b4-a9350e_D2
Tumor
0.0
bd266bdd-12e4-42cb-9c49-911bfc_D2
Tumor
0.0
9c8e78bf-b03e-4ba0-9909-5ff070_D2
Tumor
0.0
d4791079-c826-4fc7-9d9b-ee20ba_D2
Tumor
0.0
4ccb249a-6722-491e-97e9-e3b4e7_D2
Tumor
0.0
6e209757-a7f4-45af-b5f3-2ebc02_D2
Normal
-0.1
c17b0ff9-9057-4848-a0cc-abb25f_D2
Tumor
-0.1
efc971f8-54c5-4531-a792-705ecf_D2
Tumor
-0.1
7c7ce2d7-6c8a-424e-8e6c-d14ad1_D2
Tumor
-0.1
46c73531-f531-4ec3-97fe-b39d9d_D2
Tumor
-0.1
e9d416e7-f661-400a-896e-388545_D2
Tumor
-0.1
f6c215ea-5381-4521-bb61-be8e97_D2
Tumor
-0.1
50997c44-1c8b-4d34-b535-4a6cc2_D2
Tumor
-0.1
76e77c6b-c80e-4391-bdbb-e1dcea_D2
Tumor
-0.1
cfd76f9a-ce60-4ec7-8e6b-a8fc31_D3
Tumor
-0.1
a8853382-b726-4ce8-98d5-ca89df_D2
Tumor
-0.1
51a4ce2f-4166-4c6b-a7e0-942d0a_D2
Tumor
-0.2
1556af7e-c2ae-4fce-9aae-87c459_D1_D2
Normal
-0.2
2115808b-6a0d-49bc-a8d7-b83bde_D2
Tumor
-0.2
3dcf8b3c-c0c5-4dfa-9543-5d30fb_D2
Tumor
-0.2
27f3ca2d-a86f-479d-8e7e-5307c7_D2
Tumor
-0.2
161317f3-1a39-438e-af45-cd2502_D2
Tumor
-0.2
61f76fe6-a1c6-41b8-bdc2-2f9209_D2
Normal
-0.2
3490835c-c004-45ed-91f3-7c206f_D2
Tumor
-0.2
ce1e5dfc-2ef1-4633-af93-5ea4d9_D2
Tumor
-0.2
7d953d1d-84b6-4ecd-b1d7-1ed865_D2
Tumor
-0.2
42d860a3-8a0c-4c44-a09a-9ad8cf_D2
Tumor
-0.2
eb0a53df-7620-4024-8d2d-051142_D2
Tumor
-0.3
7edfd606-4bee-4529-9fec-1ca7f0_D2
Normal
-0.3
b22659b9-e12c-4725-a7db-a833de_D1_D2
Normal
-0.3
9a7a86d3-bbf2-4d36-941d-c75c03_D1_D2
Tumor
-0.3
7069e990-4a4e-4984-a66d-4d835a_D2
Tumor
-0.3
3fbf076a-824b-4eac-b6dc-bf5e59_D2
Normal
-0.3
15524912-685a-47ce-a824-567848_D2
Tumor
-0.3
69d552be-7cb2-4bb4-b602-a27b3e_D2
Tumor
-0.3
994f9b8e-46cb-413f-8ec8-2c2fed_D2
Normal
-0.3
6319b36b-533c-4e86-8e12-80552e_D3
Tumor
-0.3
91b287fd-eadb-442d-abcd-20b741_D2
Tumor
-0.3
31c15e30-21d4-4843-bd4a-9cd0d8_D2
Normal
-0.3
05387aad-2a1f-42c2-8d6f-950598_D3
Tumor
-0.4
e23eb014-69c1-460a-b9d4-9786c8_D2
Normal
-0.4
685ec3c2-e67a-40d3-9eb3-aa01c9_D1_D2
Normal
-0.4
3e746bea-ed68-40e6-b348-6ddf08_D2
Normal
-0.4
318d53c3-216b-4de1-a098-77d6dd_D2
Tumor
-0.4
a583d3ff-8165-43e9-b764-23b7ef_D1_D2
Normal
-0.4
6530147a-efe9-4df6-ac2f-03ece3_D2
Tumor
-0.4
80873a0c-1f40-4d51-bab1-3f2071_D2
Tumor
-0.4
8ed739dd-ae0f-4881-971a-db3cf4_D1_D2
Normal
-0.4
092af714-b97a-457c-b0e9-8c20e8_D2
Normal
-0.4
9b90eb78-2f50-4aeb-b010-d642f9_D2
Tumor
-0.5
1772e913-f62e-446a-8cf3-720348_D2
Tumor
-0.5
285fed94-1495-448e-879b-b55de9_D2
Tumor
-0.5
52c064a7-78d9-4a1a-85b4-27c6d1_D2
Tumor
-0.5
d109a3c0-350e-47f5-bda0-61899c_D2
Tumor
-0.5
5c3971ee-87c7-4dff-b66e-f18892_D2
Tumor
-0.5
e7b656bf-3c34-4ba1-bdf3-c7eefe_D2
Tumor
-0.5
2b73e01c-347a-4dae-a71d-752aeb_D2
Normal
-0.5
2224c03f-b7b1-4368-887e-2b4cdf_D2
Tumor
-0.5
e6850782-fd2a-4c53-b682-1852fe_D2
Tumor
-0.5
3a380577-c134-47ba-a1ce-988d7c_D2
Tumor
-0.5
2dc28da8-7ff1-4b9b-b5bd-17cc25_D2
Tumor
-0.5
1db5574d-aca7-403c-8100-6e705f_D2
Normal
-0.5
d38f40fb-dd78-43b2-8b7b-4b6977_D2
Tumor
-0.5
2563cb02-d58a-4286-8634-7502cd_D2
Tumor
-0.5
1de8d3d8-fc0e-4be0-8aa7-127c7b_D2
Tumor
-0.6
a65d8e76-640f-4341-a561-afbb57_D2
Normal
-0.6
627e6e36-3dca-4ee5-9755-6f3510_D2
Tumor
-0.6
1a10c200-3895-4648-b951-94f99f_D2
Tumor
-0.7
fe83e13f-9754-403b-8f74-d6caf8_D2
Tumor
-0.7
347e379b-77c0-4dd3-aa25-18c9d1_D2
Tumor
-0.7
1b2ab076-c72f-4bbe-b9f9-657d24_D2
Tumor
-0.7
2b4ce90c-8036-4207-ac3e-54a76f_D2
Tumor
-0.7
558333b0-ea23-4303-9e3c-4932b1_D2
Tumor
-0.7
79b60f32-6cca-4cb6-9a1e-22a3ac_D2
Tumor
-0.7
28d0abdb-f682-4bd3-9425-a9c508_D2
Tumor
-0.7
af95e2c6-25c4-4ab8-bf06-3e15ff_D2
Tumor
-0.7
8234f8ea-bdbd-45b0-bd0b-16f1e7_D2
Tumor
-0.7
49bd51fe-48a1-4828-b66e-b30c38_D2
Tumor
-0.7
2433b136-fc7b-4cea-b958-bc6efb_D2
Tumor
-0.8
62f5840e-6cd7-4200-b651-645e53_D2
Tumor
-0.8
a03d1103-b809-42c4-ad5c-5aff58_D2
Tumor
-0.8
41d0619e-b299-42e2-ac32-29e784_D2
Tumor
-0.8
1abbcb28-f221-4cd4-8c01-37b9bb_D1_D2
Normal
-0.8
2f901c90-617e-46da-9fac-d68369_D2
Tumor
-0.9
0745488e-0bfb-4d1f-8228-dedf76_D1_D2
Normal
-0.9
b9c1f22e-61f7-45ed-b3b4-5094c7_D2
Normal
-0.9
21efd60f-6a31-4b98-9477-16a905_D2
Normal
-0.9
3d3e1888-d67e-4c69-ba83-112d0f_D2
Tumor
-0.9
a3a26070-fb84-406a-8280-d555e6_D2
Normal
-0.9
1c9145ad-1981-4871-aa7e-8b11de_D2
Tumor
-1.0
340a3769-3031-41ae-bb08-a2f696_D2
Normal
-1.0
256ac9f5-1e19-44b4-92fb-fef3fc_D2
Tumor
-1.2
Show allShow less
OVARIAN CANCER - Protein expressioni
A mouse-over function shows sample information and annotation data. Click on an image to view it in a full screen mode. Samples can be filtered based on level of antibody staining by selecting one or several of the following categories: high, medium, low and not detected. The assay and annotation is described here.
Note that samples used for immunohistochemistry by the Human Protein Atlas do not correspond to samples in the TCGA dataset.